Clinical Trial Update: An Open Label Phase I/II Study of the Safety and Dopamine Transporter Binding Properties of C-11 Altropane in Normal Human Subjects and in Subjects With ADHD

View source ↗

Summary

An open-label Phase I/II trial evaluated the safety and dopamine transporter binding properties of the PET tracer C-11 Altropane in healthy volunteers and indiv…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Attention Deficit Hyperactivity Disorder

Drugs mentioned

• C-11 Altropane (Altropane)

Snippet

Sponsor: Massachusetts General Hospital | Conditions: Attention Deficit Hyperactivity Disorder | Status: COMPLETED